3 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
The DNA damage response and breast cancer (DDRESPONSE)
Date du début: 1 févr. 2011, Date de fin: 31 janv. 2015,
We will exploit the DNA damage response (DDR) to assess and predict individual susceptibility and response focussed on breast cancer and breast cancer therapies. The 1st targeted therapy based on the DDR is inhibition of PARP by olaparib, which induces synthetic lethality in cancer cells with a specific DDR defect. Our members discovered olaparib, which is currently in Phase II trials. Its use in ...
Voir le projet
6
Participants partenaires
TERMINÉ
Characterization and quantitative modeling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance (mismatch2model)
Date du début: 1 nov. 2008, Date de fin: 31 oct. 2012,
Mismatch2model: Characterization and quantitative modeling of DNA mismatch repair and its role in the maintenance of genomic stability and cancer avoidance DNA mismatch repair (MMR) plays a crucial role in the maintenance of genomic stability. In both bacteria and eukaryotes, the loss of mismatch repair gives rise to a mutator phenotype. In hereditary non-polyposis colon cancer (HNPCC) families, ...
Voir le projet
6
Participants partenaires
TERMINÉ
Neuron-Glia Interactions in Nerve Development and Disease (NGIDD)
Date du début: 1 avr. 2008, Date de fin: 31 mars 2012,
"The characteristic appearance of white matter in the nervous system results from a remarkable cellular structure called myelin. This membraneous sheath is wrapped around axons by dedicated glial cells, thereby allowing the rapid propagation of impulses along the axons. The importance of the myelin sheath is underscored by the many neurological diseases that are caused by loss or destabilization o ...
Voir le projet